Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Efficacy of clarithromycin in pityriasis rosea
Najia Ahmed1, Nadia Iftikhar2, Uzma Bashir3
1Department of Dermatology, Combined Military Hospital, Multan.
Objective:
To determine the efficacy of clarithromycin in the treatment of Pityriasis Rosea (PR).
Study Design:
Double blind randomized controlled trial.
Place And Duration Of Study:
Dermatology OPD, Military Hospital, Rawalpindi, from July 2008 to July 2009.
Methodology:
Patients aged above 10 years, diagnosed with PR, were randomly assigned to two groups of 30 each to receive either clarithromycin or similar-looking placebo for one week. Neither the patient nor the treating physician knew to which group the patient belonged. Patients were assessed at 1, 2, 4 and 6 weeks after presentation and compared for complete, partial or no response.
Results:
Among the 60 patients, no significant difference was found between the two groups at 2 weeks after presentation (p = 0.598). In the placebo group, complete response was seen in 20 (66.7%), partial response in 3 (10.0%) while no response was seen in 7 (23.3%). In clarithromycin group, there was complete response in 23 (76.7%), partial response in 3 (10.0%) and no response in 4 (13.3%) patients.
Conclusion:
Clarithromycin is not effective in treatment of pityriasis rosea.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Myocarditis III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Acne Infection
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Drugs for Treatment of Ulcerative Colitis in IBD

